ESMO 2022 Conference Coverage


 

Lecture Summary - ESMO 2022 on the INCREASE Trial: Ipi + Nivo & CRT Followed by Surgery in Resectable and Borderline-Resectable Lung Cancer

10 views
September 27, 2022
Comments 0
Login to view comments. Click here to Login